AU Patent

AU2023334610A1 — Novel ionizable lipids and lipid nanoparticles and methods of using the same

Assigned to Sail Biomedicines Inc · Expires 2025-03-13 · 1y expired

What this patent protects

Novel ionizable lipids and lipid nanoparticles that can be used in the delivery of therapeutic cargos are disclosed.

USPTO Abstract

Novel ionizable lipids and lipid nanoparticles that can be used in the delivery of therapeutic cargos are disclosed.

Drugs covered by this patent

Onpattro (PATISIRAN SODIUM) · Alnylam Pharmaceuticals

Patent Metadata

Patent number: AU2023334610A1
Jurisdiction: AU
Classification: —
Expires: 2025-03-13
Drug substance claim: No
Drug product claim: No
Assignee: Sail Biomedicines Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.